Novel approach reverses age-related cognitive decline

The authors investigate the physiological functions of Terc-53 by creating transgenic mice that overexpress this noncoding RNA. They observe that Terc-53 overexpression affects normal aging in mammals, contributing to cognitive decline and shortened lifespan.

How Boehringer Ingelheim and Pfizer battled over the exclusivity of the first Humira interchangeable

Ten companies are now competing for market share with AbbVie’s megablockbuster rheumatoid arthritis drug Humira (adalimumab), but two of those competitors — Pfizer and Boehringer

November 10, 2023

Opinion | ‘There’s No Cops on the Beat’: What We Heard This Week

“A lot of this stuff that happens is because there’s no cops on the beat.” — Vikas Saini, MD, president of the Lown Institute, discussing

January 13, 2025

COTA and FDA Extend Collaboration to Advance Use of Real-World Data in Cancer Research

What You Should Know: – COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the

May 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.